The Valley Desk

ReviewAgeing research reviewsPublished

Donanemab, another anti-Alzheimer's drug with risk and uncertain benefit

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Hospital of the University of Pennsylvania, with Penn Medicine linked by the institution reference. Affiliation source

Publication record

Type
Review
Venue
Ageing research reviews
Published
Subject terms
Humans; Alzheimer Disease; Antibodies, Monoclonal, Humanized; Alzheimer’s disease; Fdg-pet; Brain Volume; Aria; Amyloid-pet; Aducanumab; Lecanemab; Donanemab
PubMed ID
38830549
Added to directory
Source checked

Report a correction or request removal